Looks like we have a more defined timeline for Corum Clear Dispense to be released, based on the Corum stand at the Pharmaceutical Society of Australia Conference in Sydney this week.
I don't think we should forget that Corum have launched other products in the last 12 months like Corum Safeguard, so those along with a good control on costs and lower R&D spend should have seen a decent half.
It is a decent point about competitors, instead of doing a whole bunch of R&D yourself and investing $5m in that, just buy Corum for $14m, pocket their cash $6m, sell the payments business $1m and gain a large group of customers, all for what you were going to spend on R&D and updating your own tech anyway. Obviously needs support from a few key individuals to even be entertained, but someone would have to be looking at it.
COO Price at posting:
3.0¢ Sentiment: Buy Disclosure: Held
